期刊
NEUROBIOLOGY OF AGING
卷 56, 期 -, 页码 25-32出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2017.04.004
关键词
Cerebrospinal fluid; Preclinical Alzheimer disease; Neuropsychological measures; Subtle cognitive decline
资金
- National Institute on Aging [P01AG026276]
Identifying which neuropsychological measures detect early cognitive changes associated with Alzheimer disease (AD), brain pathology would be helpful clinically for the diagnosis of early AD and for the design of clinical trials. We evaluated which neuropsychological measures in our cognitive battery are most strongly associated with cerebrospinal fluid (CSF) biomarkers of AD brain pathology. We studied a large cohort (n = 233) of middle- to older-aged community-dwelling individuals (mean age 61 years) who had no clinical symptoms of dementia and underwent baseline CSF collection at baseline. Participants completed a battery of 9 neuropsychological measures at baseline and then every 1 to 3 years. CSF tau/A beta 42 was associated with baseline performance on 5/9 neuropsychological measures, especially measures of episodic memory, and longitudinal performance on 7/9 neuropsychological measures, especially measures of global cognition. The free recall portion of the Free and Cued Selective Reminding Task (FCSRT-free) detected declining cognition in the high CSF tau/A beta 42 group the earliest, followed by another measure of episodic memory and a sequencing task. (C) 2017 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据